The Biologic Research Collective

The GH Pulse

“Decoding growth hormone secretagogue receptor pharmacology”

This division covers investigational research on GHRH and GHRP compounds, somatotroph signaling, GHS-R1a receptor agonism, and the GH/IGF-1 axis — including CJC-1295, Ipamorelin, GHRP-6, and Sermorelin. All content is presented for scientific education only.

Research Focus

GHS-R1a Receptor Agonism & Somatotroph Signaling

Coverage Area

GHRH/GHRP Compound Pharmacology & GH/IGF-1 Axis

Methodology

Endocrinology Literature Review & Translational Research Analysis

Research Intelligence

Get Daily Research Breakdowns

Receive curated summaries of the latest GHRP and GHRH research, somatotroph pharmacology studies, and GH secretagogue mechanism analyses — delivered to your inbox.

No commercial content. Unsubscribe at any time.

Latest Research

Featured Articles

View All →

GHRH/GHRP
Sermorelin

What Current Research Suggests About Sermorelin in GHRH Receptor Agonism

A review of current preclinical and clinical research on Sermorelin’s mechanism of action at the GHRH receptor, examining its role as a 29-amino acid synthetic analog and the implications for somatotroph pharmacology research.

Read Full Analysis →

Browse by Research Area

GHRP-6

Hexapeptide GHS-R1a agonism studies

Other GHRH/GHRP Compounds

Broad-spectrum secretagogue research

CJC-1295

Long-acting GHRH analog pharmacology

Ipamorelin

Selective GH secretagogue mechanism

All research presented in The GH Pulse is sourced from publicly available peer-reviewed literature. This content is intended for educational and research purposes only and does not constitute medical advice. The Biologic Research Collective operates under strict scientific editorial standards.